Risks and limits of Menopause Test

Direct-to-consumer menopause tests (e.g., measuring FSH, estradiol from saliva or blood) have significant limitations. Menopause is clinically defined by menstrual history, not by a single hormone level. Hormone levels fluctuate greatly during perimenopause; a single FSH value can be misleading. These tests provide a snapshot, not a diagnosis. Many companies explicitly state they offer 'lifestyle insights, not medical statements.' They often lack independent validation and FDA clearance. Risks include false reassurance or unnecessary anxiety, and they should never be used to start hormone therapy without a doctor. Evidence: marketing/unclear. Sources: none provided in context. Caveat: For accurate assessment, consult a healthcare provider for clinical evaluation and lab testing.